Business

Heating oil suppliers ‘blatantly profiteering’ from Mid...

Conservative MP Harriet Cross calls for CMA investigation, saying some suppliers...

Portland small businesses feel squeeze of costs and bur...

Owners cite higher expenses, taxes and reputation concerns as key pressures.

CarMax Stock: Auto Business Activist Investor Takes Stake

CarMax stock rose over 7% in premarket trading. Starboard eyes a turnaround for ...

Google closes its $32 billion acquisition of Wiz

Google has officially bought cybersecurity company Wiz, marking the search giant...

Washington House passes 9.9% ‘millionaires tax’ as busi...

Some tech leaders and entrepreneurs worry the legislation could undermine their ...

Insights from R.I. business leaders on surviving and th...

From a fast-growing startup to a restaurant owner to the chairman of Rhode Islan...

Newberry business owners react to city’s growth

Business owners in Newberry are working to manage the positive and negative aspe...

Opinion: Georgia risks 'best state to do business' stat...

Georgia is a leader in data center growth and construction, but those gains coul...

Yamaha is leaving California after nearly 50 years

Yamaha Motor Corp. U.S.A. is the latest company to leave California, seeking inc...

Japan Lobby to Steer Banks on Tackling Booming LBO Busi...

Japan’s main banking lobby plans to establish risk management guidelines for len...

How Steve Jobs' intense meetings shaped Apple's culture

David Pogue's new book on Apple reveals how Steve Jobs' meeting strategy and lea...

How a print paper from Brooklyn is trying to reach the ...

"People know this is a place they can turn to that they can give us that gossip,...

National Write Your Congressman Q1 2026 Index: Small Bu...

National Write Your Congressman (NWYC), an organization that gives small busines...

Minnesota businesses hit by now-cancelled tariffs are l...

The Supreme Court ruled President Donald Trump’s tariffs illegal, but did not ge...

Minerva Neurosciences Reports Fourth Quarter and Fiscal...

Initiation of confirmatory Phase 3 trial with roluperidone for negative symptoms...

Protalix BioTherapeutics to Announce Fiscal Year 2025 F...

/PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharma...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.